Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George B Rodrigues

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Practical Radiation Oncology|July 4, 2021
Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical TrialsSerenna G Gerhard, David A Palma, Andrew J Arifin, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factorsGwendolyn H M J Griffioen, Daniel Toguri, Max Dahele, et al.
Acta Oncologica (Stockholm, Sweden)|October 29, 2014
Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapySpencer Martin, Carol Johnson, Mark Brophy, et al.
The Journal of Urology|August 27, 2021
Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and OpportunitiesMark T Corkum, D Andrew Loblaw, Gerard Morton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Accuracy of recorded tumor, node, and metastasis stage in a comprehensive cancer centerJames D Brierley, Pamela A Catton, Brian O'Sullivan, et al.
Radiation Oncology (London, England)|January 14, 2021
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [<sup>18</sup>F]FDG PET and CT perfusion: a prospective exploratory clinical studyDae-Myoung Yang, David A Palma, Keith Kwan, et al.
JAMA Oncology|February 22, 2019
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical TrialDavid A Palma, Timothy K Nguyen, Alexander V Louie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2020
Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, CanadaMark T Corkum, Gerard Morton, Alexander V Louie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2004
Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?Edward Yu, Rashid Dar, George B Rodrigues, et al.
BMC Cancer|December 13, 2019
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trialDavid A Palma, Hanbo Chen, Houda Bahig, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Practical Radiation Oncology|July 4, 2021
Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical TrialsSerenna G Gerhard, David A Palma, Andrew J Arifin, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2013
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factorsGwendolyn H M J Griffioen, Daniel Toguri, Max Dahele, et al.
Acta Oncologica (Stockholm, Sweden)|October 29, 2014
Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapySpencer Martin, Carol Johnson, Mark Brophy, et al.
The Journal of Urology|August 27, 2021
Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and OpportunitiesMark T Corkum, D Andrew Loblaw, Gerard Morton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Accuracy of recorded tumor, node, and metastasis stage in a comprehensive cancer centerJames D Brierley, Pamela A Catton, Brian O'Sullivan, et al.
Radiation Oncology (London, England)|January 14, 2021
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [<sup>18</sup>F]FDG PET and CT perfusion: a prospective exploratory clinical studyDae-Myoung Yang, David A Palma, Keith Kwan, et al.
JAMA Oncology|February 22, 2019
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical TrialDavid A Palma, Timothy K Nguyen, Alexander V Louie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 28, 2020
Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, CanadaMark T Corkum, Gerard Morton, Alexander V Louie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2004
Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?Edward Yu, Rashid Dar, George B Rodrigues, et al.
BMC Cancer|December 13, 2019
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trialDavid A Palma, Hanbo Chen, Houda Bahig, et al.
Pageof 9